Category: Fresenius Medical Care
Fresenius Medical Care acquires Cogent Healthcare and its specialty physicians business for an unspecified amount as it looks to build a $5 billion coordinated care operation.
Economic sanctions against Russia over the Ukraine crisis prompt Fresenius to scrap a Russian joint venture.
Here's a look at some of the top legal news stories for medical device companies this week: J&J's Conor MedSystems can't slip $100M Biotronik lawsuit; Supreme Court declines review of Baxter/Fresenius patent row; Medtronic, Edwards ink $750M heart valve settlement; Pa. Supreme Court to review $28M Zimmer verdict; Laid off Italian workers sue Haemonetics.
Fresenius escapes for good a $24 million patent infringement loss to dialysis rival Baxter International after the U.S. Supreme court declines to review the case.
Dialysis services provider Fresenius gives its renal research arm a new look, renaming it "Frenova" and reasserting its focus on new product development.
Dialysis giant Fresenius (NYSE:FMS) re-introduced its renal research branch, renaming it "Frenova" and reiterating the group's commitment to developing novel therapies.
Here's a look at some of the top Wall Street stories for medical device companies this week.
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
, Goldman Sachs
, Kohlberg Kravis Roberts & Co. L.P.
, Semler Scientific
, Terumo Corp.
, The Blackstone Group LP
, TPG Capital
, Analogic Corp.
, Fresenius Medical Care
, GE Healthcare
, Getinge AB
QMed releases a list of the 5 worst-performing medical device companies of early 2014, including Siemens, GE and Fresenius, among others.
MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company's in the industry's top 40 haven't been so fortunate.